Danilo Santos Teixeira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Danilo Santos Teixeira has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Catarina Teixeira
Laboratory of Pharmacology, Instituto Butantan, São Paulo, Brazil
4 shared publications - Rodrigo Maia-Marques
Lab. de Farmacologia, Instituto Butantan, São Paulo-SP, Brazil
4 shared publications Elbio Leiguez
Affiliation Laboratório de Farmacologia, Instituto Butantan, São Paulo, São Paulo, Brazil
3 shared publicationsPriscila Signor Motta
Laboratory of Pharmacology, Butantan Institute, São Paulo, Brazil; Center of Excellence in New Target Discovery (CENTD), Butantan Institute, Sâo Paulo, Brazil
2 shared publicationsCarlos DeOcesano-Pereira
Affiliation Center of Excellence in New Target Discovery (CENTD), Instituto Butantan, São Paulo, São Paulo, Brazil
1 shared publication- Priscila Motta Janovits
Laboratório de Farmacologia, Instituto Butantan, São Paulo 05503-900, Brazil
1 shared publication
Latest Publications
- Open Access
- 23 June 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (10) , 4281-4289
Crotalus durissus terrificus snake venom activates 3T3-L1 preadipocytes to release PGE2, which depends on COX-2 expression and is modulated by PGE2 EP2 receptor
Snakebites are a worldwide public health problem with high-cost treatment in many countries. Crotalus genus snakes, commonly known as rattlesnakes, cause the most lethal snakebites in Brazil. Crotalus ssp envenomation is characterised by systemic neurotoxicity, myotoxicity, renal failure and minor local effects. Despite the knowledge of envenomation’s pathogenesis, the impact of Crotalus venom on adipose tissue (AT) cells is unknown. AT is an endocrine organ capable of releasing diverse immunomodulatory molecules, including prostaglandin E2 (PGE2). Herein, we investigated the effects of Crotalus durissus terrificus venom (CdtV) on preadipocytes in vitro, focussing on the release of PGE2 and mechanisms involved. CdtV (5 and 10 μg/mL) induced a marked release of PGE2 by preadipocytes (3–24 h) compared to controls. Pre-treatment of cells with SC-560 or NS-398, selective inhibitors for cyclooxygenase (COX)-1 and COX-2 enzymes, respectively, decreased CdtV-induced PGE2 release after 24 h. CdtV (1 and 10 μg/mL) did not change COX-1 protein expression by preadipocytes, but induced COX-2 protein expression at all time intervals evaluated. Pre-treating preadipocytes with AH6809, an inhibitor of the PGE2 EP2 receptor, significantly increased the CdtV-induced PGE2 release. EP1, EP3, or EP4 receptor antagonists did not change the CdtV-induced PGE2 release. Additionally, CdtV did not alter the EP2 receptor protein expression in preadipocytes. These findings demonstrate that CdtV activates preadipocytes to produce PGE2 via COX-1 activation and COX-2 protein expression and PGE2 triggers a negative feedback loop via EP2 for its own production. These results highlight AT as another target for CdtV that may contribute to envenomation.
- 23 June 2025
- Published by Springer Nature in Archives of Toxicology
- Vol. 99 (10) , 4281-4289
Open AccessCrotalus durissus terrificus snake venom activates 3T3-L1 preadipocytes to release PGE2, which depends on COX-2 expression and is modulated by PGE2 EP2 receptor
Snakebites are a worldwide public health problem with high-cost treatment in many countries. Crotalus genus snakes, commonly known as rattlesnakes, cause the most lethal snakebites in Brazil. Crotalus ssp envenomation is characterised by systemic neurotoxicity, myotoxicity, renal failure and minor local effects. Despite the knowledge of envenomation’s pathogenesis, the impact of Crotalus venom on adipose tissue (AT) cells is unknown. AT is an endocrine organ capable of releasing diverse immunomodulatory molecules, including prostaglandin E2 (PGE2). Herein, we investigated the effects of Crotalus durissus terrificus venom (CdtV) on preadipocytes in vitro, focussing on the release of PGE2 and mechanisms involved. CdtV (5 and 10 μg/mL) induced a marked release of PGE2 by preadipocytes (3–24 h) compared to controls. Pre-treatment of cells with SC-560 or NS-398, selective inhibitors for cyclooxygenase (COX)-1 and COX-2 enzymes, respectively, decreased CdtV-induced PGE2 release after 24 h. CdtV (1 and 10 μg/mL) did not change COX-1 protein expression by preadipocytes, but induced COX-2 protein expression at all time intervals evaluated. Pre-treating preadipocytes with AH6809, an inhibitor of the PGE2 EP2 receptor, significantly increased the CdtV-induced PGE2 release. EP1, EP3, or EP4 receptor antagonists did not change the CdtV-induced PGE2 release. Additionally, CdtV did not alter the EP2 receptor protein expression in preadipocytes. These findings demonstrate that CdtV activates preadipocytes to produce PGE2 via COX-1 activation and COX-2 protein expression and PGE2 triggers a negative feedback loop via EP2 for its own production. These results highlight AT as another target for CdtV that may contribute to envenomation.
- Open Access
- 8 August 2022
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (8) , e0010658
Bothrops moojeni snake venom induces an inflammatory response in preadipocytes: Insights into a new aspect of envenomation
Bothropsenvenomation is a public health problem in Brazil. Despite the advances in the knowledge of the pathogenesis of systemic and local effects induced byBothropsvenom, the target tissues to this venom are not completely characterised. As preadipocytes are important cells of the adipose tissue and synthesize inflammatory mediators, we investigated the ability ofB.moojenisnake venom (Bmv) to stimulate an inflammatory response in 3T3-L1 preadipocytesin vitro, focusing on (1) the release of PGE2, IL-6, TNF-α, MCP-1, KC, leptin and adiponectin; (2) the mechanisms involved in PGE2release and (3) differentiation of these cells. Cytotoxicity of Bmv was determined by MTT assay. The concentrations of PGE2, cytokines and adipokines were quantified by EIA. Participation of the COX-1 and COX-2 enzymes, NF-κB and PGE2receptors (EP1-4) was assessed using a pharmacological approach, and protein expression of the COX enzymes and P-NF-κB was analysed by western blotting. Preadipocyte differentiation was quantified by Oil Red O staining. Bmv (1 μg/mL) induced release of PGE2, IL-6 and KC and increased expression of COX-2 in preadipocytes. Basal levels of TNF-α, MCP-1, leptin and adiponectin were not modified. Treatment of cells with SC560 (COX-1 inhibitor) and NS398 (COX-2 inhibitor) inhibited Bmv-induced PGE2release. Bmv induced phosphorylation of NF-κB, and treatment of the cells with TPCK and SN50, which inhibit distinct NF-κB domains, significantly reduced Bmv-induced PGE2release, as did the treatment with an antagonist of PGE2receptor EP1, unlike treatment with antagonists of EP2, EP3 or EP4. Bmv also induced lipid accumulation in differentiating cells. These results demonstrate that Bmv can activate an inflammatory response in preadipocytes by inducing the release of inflammatory mediators; that PGE2production is mediated by the COX-1, COX-2 and NF-κB pathways; and that engagement of EP1 potentiates PGE2synthesis via a positive feedback mechanism. Our findings highlight the role of the adipose tissue as another target for Bmv and suggest that it contributes toBothropsenvenomation by producing inflammatory mediators.
- 8 August 2022
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (8) , e0010658
Open AccessBothrops moojeni snake venom induces an inflammatory response in preadipocytes: Insights into a new aspect of envenomation
Bothropsenvenomation is a public health problem in Brazil. Despite the advances in the knowledge of the pathogenesis of systemic and local effects induced byBothropsvenom, the target tissues to this venom are not completely characterised. As preadipocytes are important cells of the adipose tissue and synthesize inflammatory mediators, we investigated the ability ofB.moojenisnake venom (Bmv) to stimulate an inflammatory response in 3T3-L1 preadipocytesin vitro, focusing on (1) the release of PGE2, IL-6, TNF-α, MCP-1, KC, leptin and adiponectin; (2) the mechanisms involved in PGE2release and (3) differentiation of these cells. Cytotoxicity of Bmv was determined by MTT assay. The concentrations of PGE2, cytokines and adipokines were quantified by EIA. Participation of the COX-1 and COX-2 enzymes, NF-κB and PGE2receptors (EP1-4) was assessed using a pharmacological approach, and protein expression of the COX enzymes and P-NF-κB was analysed by western blotting. Preadipocyte differentiation was quantified by Oil Red O staining. Bmv (1 μg/mL) induced release of PGE2, IL-6 and KC and increased expression of COX-2 in preadipocytes. Basal levels of TNF-α, MCP-1, leptin and adiponectin were not modified. Treatment of cells with SC560 (COX-1 inhibitor) and NS398 (COX-2 inhibitor) inhibited Bmv-induced PGE2release. Bmv induced phosphorylation of NF-κB, and treatment of the cells with TPCK and SN50, which inhibit distinct NF-κB domains, significantly reduced Bmv-induced PGE2release, as did the treatment with an antagonist of PGE2receptor EP1, unlike treatment with antagonists of EP2, EP3 or EP4. Bmv also induced lipid accumulation in differentiating cells. These results demonstrate that Bmv can activate an inflammatory response in preadipocytes by inducing the release of inflammatory mediators; that PGE2production is mediated by the COX-1, COX-2 and NF-κB pathways; and that engagement of EP1 potentiates PGE2synthesis via a positive feedback mechanism. Our findings highlight the role of the adipose tissue as another target for Bmv and suggest that it contributes toBothropsenvenomation by producing inflammatory mediators.